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aBstraCt
introduction: Legislation requires the U.S. Food and Drug Administration (FDA) to release information to the public about 
harmful constituents in tobacco and tobacco smoke. To inform these efforts, we sought to better understand how smokers and 
nonsmokers think about tobacco constituents.
Methods: In October 2012, 300 U.S.  adults aged 18–66 years completed a cross-sectional Internet survey. The questions 
focused on 20 harmful tobacco constituents that the FDA has prioritized for communicating with the public.
results: Most participants had heard of 7 tobacco constituents (ammonia, arsenic, benzene, cadmium, carbon monoxide, for-
maldehyde, and nicotine), but few participants had heard of the others (e.g., acrolein). Few participants correctly understood that 
many constituents were naturally present in tobacco. Substances that companies add to cigarette tobacco discouraged people from 
wanting to smoke more than substances that naturally occur in cigarette smoke (p < .001). Ammonia, arsenic, carbon monoxide, 
and formaldehyde being in cigarettes elicited the most discouragement from smoking. Constituents elicited greater discourage-
ment from wanting to smoke if respondents were nonsmokers (β = −.34, p < .05), had negative images of smokers (i.e., negative 
smoker prototypes; β = .19, p < .05), believed constituents are added to tobacco (β = .14, p < .05), or were older (β = .16, p < .05).
Conclusions: Our study found low awareness of most tobacco constituents, with greater concern elicited by additives. Efforts 
to communicate health risks of tobacco constituents should consider focusing on ones that elicited the most discouragement 
from smoking.
intrODuCtiOn
Cigarette smoking causes around one of five deaths in the 
United States, or more than 440,000 deaths per year, primar-
ily from cardiovascular disease, cancer, and respiratory disease 
(Centers for Disease Control and Prevention, 2012a; Mokdad, 
Marks, Stroup, & Gerberding, 2004). Most of the harms from 
smoking come from tobacco constituents that are naturally 
present in tobacco (Hecht, 2012). Manufacturers also add sub-
stances, called additives, such as flavors. Some substances, like 
ammonia and nicotine, are classified as constituents because 
they are naturally present in tobacco but are also sometimes 
added to tobacco products by tobacco manufacturers (Wayne 
& Carpenter, 2009).
Tobacco products and cigarette smoke contain more than 
5,000 constituents, many of which are toxic to human health 
(Rodgman & Perfetti, 2008; Talhout et  al., 2011; U.S. Food 
and Drug Administration, 2012b). Carcinogenic constituents 
include 1,3-butadiene, formaldehyde, nicotine-derived nitros-
amine ketone (NNK), N-nitrosonornicotine, and benzene 
(Biener, Nyman, Stepanov, & Hatsukami, 2013; Fowles & 
Dybing, 2003; Hecht, 2012; International Agency for Research 
on Cancer, 2004). Acrolein and acetaldehyde are two of the 
most harmful constituents to respiratory health, and arsenic 
and hydrogen cyanide pose great cardiovascular health risk 
(Fowles & Dybing, 2003). In addition to direct health effects, 
some of these constituents (e.g., nicotine) may cause indirect 
harm to consumers by hindering cessation or leading to higher 
intensity or frequency of tobacco use (U.S. Food and Drug 
Administration, 2011).
Federal law requires the U.S. Food and Drug Administration 
(FDA) to disseminate information about tobacco constituents. 
The 2009 Family Smoking Prevention and Tobacco Control Act 
grants FDA broad authority to regulate tobacco products, includ-
ing helping the public to better understand the harms of con-
stituents present in tobacco products (United States Public Laws, 
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2009). The FDA identified 93 such constituents in tobacco prod-
ucts and tobacco smoke (U.S. Food and Drug Administration, 
2012a) and later released an abbreviated list of 20 high-
priority harmful tobacco constituents (U.S. Food and Drug 
Administration, 2012b). In 2012, FDA required manufacturers 
to submit quantities of constituents for their cigarette brands on 
the abbreviated list (U.S. Food and Drug Administration, 2012b; 
United States Public Laws, 2009). In 2013, FDA is required 
to release this information to the public in a way that is both 
“understandable” and “not misleading” (U.S. Food and Drug 
Administration, 2011). This event will mark the first time that 
smokers will ever see brand-specific constituent information.
Investigating awareness of and attitudes toward constituents 
can inform strategies to effectively communicate the health 
risks associated with harmful and potentially harmful constitu-
ents to smokers and nonsmokers. However, very little is known 
about the public’s perception of tobacco constituents and 
whether they discourage smoking. For example, it is unclear 
whether lesser-known constituents elicit more fear and con-
cern among the public than commonly known constituents that 
might be perceived as overly familiar or “worn-out.” To our 
knowledge, this is the first study to assess the extent to which 
tobacco constituents discourage people from smoking. Several 
countries, including Australia, Canada, Spain, and the United 
Kingdom, have incorporated information about constituents 
in tobacco product warnings (Hammond, 2009). If the United 
States follows suit, it will be even more important to under-
stand how the public responds to information about harmful 
constituents. Thus, our study sought to (a) characterize adults’ 
awareness of 20 constituents on FDA’s priority list of harmful 
tobacco constituents, (b) identify the extent to which these 20 
constituents discourage adults from wanting to smoke, and (c) 
identify factors that influence whether constituents discourage 
people from wanting to smoke.
MetHODs
Participants and Procedures
In October 2012, we recruited a convenience sample of 
300 U.S. cigarette smokers and nonsmokers aged 18 or older to 
complete a survey about the chemicals found in cigarettes and 
cigarette smoke. The recruitment message encouraged smokers 
to participate with text that read, “We are especially hoping for 
smokers and tobacco users to take our survey, although this is 
not required.” As health warnings can prevent smoking initia-
tion among nonsmokers and promote cessation among smokers 
(Hammond, 2011), we included both smokers and nonsmok-
ers. Recruitment happened through Amazon Mechanical 
Turk (MTurk), a web-based platform commonly used for 
social science and experimental research (Berinsky, Huber, & 
Lenz, 2012; Buhrmester, Kwang, & Gosling, 2011; Paolacci, 
Chandler, & Ipeirotis, 2010; Rand, 2012). MTurk advertises 
human intelligence tasks (HITs) to users who are invited to 
complete the HIT and receive a reward for successful comple-
tion. Our quality control procedure specified that we would 
reject a HIT if fewer than 95% of the questions were answered, 
but no HITs met this threshold for exclusion. We completed 
recruitment within 2 hr of posting the announcement. After 
providing informed consent, participants completed a 130-
item online questionnaire (mean time to completion: 20 min). 
Participants received $5 USD after completing the survey. 
The University of North Carolina at Chapel Hill Institutional 
Review Board approved this study.
Measures
Awareness, Worry, and Discouragement
The survey assessed awareness, worry, and discouragement 
for constituents in cigarette smoke. The 20 constituents appear 
on FDA’s abbreviated list of harmful and potentially harmful 
constituents to be reported by tobacco product manufactur-
ers (U.S. Food and Drug Administration, 2011), though two 
constituents (arsenic and cadmium) are on the priority list for 
smokeless tobacco, roll-your-own tobacco, and cigarette filler 
but not for cigarette smoke. The survey introduced the topic 
as being about “ingredients sometimes found in tobacco.” The 
survey assessed constituent awareness by asking participants 
if they had heard of each constituent. The survey assessed 
worry by asking “how much would [constituent] being in ciga-
rettes make you feel worried about the harms of smoking?” 
The 5-point response scale ranged from “not at all” (coded as 
1) to “very” (coded as 5). To assess discouragement, the sur-
vey asked participants “how much would [constituent] being in 
cigarettes discourage you from wanting to smoke cigarettes?” 
The 5-point response scale read “not at all” (1), “a little bit” 
(2), “somewhat” (3), “quite a bit” (4), and “very much” (5). 
The three questions appeared as a block for each constituent, 
with a different random order of blocks for each participant 
to minimize confounding due to order effects. We created a 
discouragement score, averaged across the 20 items (α = .97).
Beliefs About Sources of Constituents
The survey assessed participants’ beliefs about sources of con-
stituents in cigarettes using two methods: spontaneous recall 
and recognition of the constituent when presented. The survey 
stated, “Some chemicals or ingredients are naturally in smoke 
from burning cigarettes. Tobacco also has ‘additives,’ which are 
chemicals or ingredients that cigarette companies add.” The sur-
vey asked participants to list some of the chemicals or ingredients 
they think are naturally in cigarette smoke and to list some of 
chemicals or ingredients they think companies add to cigarette 
tobacco. Then, the survey listed the 20 constituents and asked 
participants to select whether they believed the constituent is 
naturally in tobacco smoke, added to cigarette tobacco, or both. 
We created variables for the count of the numbers of constituents 
respondents thought were naturally present and added to tobacco.
Smoker Prototype
The survey included a 12-item smoker prototype scale to meas-
ure participants’ attitudes toward smokers (McCool, Cameron, 
& Petrie, 2004; McCool, Cameron, & Robinson, 2011; Pepper 
et  al., 2013). The main question stem asked participants to 
what extent they thought that 12 adjectives described a typi-
cal person who smokes. The 5-point response scale ranged 
from “not at all” (1) to “very much” (5). For each participant, 
we calculated an average score for the seven positive charac-
teristics (stylish, tough, cool, sexy, intelligent, independent, 
and classy; α =  .86) and for the five negative characteristics 
(immature, inconsiderate, self-centered, trashy, and unattrac-
tive; α = .85). Previous studies have shown smoker prototypes 
as being highly predictive of smoking-related attitudes and 
behavior. Specifically, those who have negative perceptions 
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of the “typical smoker” are less likely to smoke (Gibbons & 
Eggleston, 1996; Gibbons, Helweg-Larsen, & Gerrard, 1995). 
A more recent study found that having more negative beliefs 
about the typical smoker was associated with lower willingness 
to try e-cigarettes (Pepper et al., 2013). Similarly, we hypoth-
esized that adults with negative images of smokers would be 
more discouraged from smoking by constituents while those 
with positive images of smokers would be less discouraged.
Demographics and Tobacco Use
The survey assessed age, sex, education, race and ethnicity, area 
of residence (rural, suburban, or urban), and annual household 
income. We also measured sexual orientation; gays, lesbians, 
and bisexuals are an important and understudied vulnerable 
group because they are much more likely to smoke than their 
heterosexual counterparts. (Centers for Disease Control and 
Prevention, 2012a; Lee, Griffin, & Melvin, 2009). We measured 
health literacy using the Newest Vital Sign, a six-item screen-
ing tool to identify individuals at risk for low literacy (Weiss 
et al., 2005). Consistent with the definition used by the Centers 
for Disease Control and Prevention, we defined current smok-
ers as those who reported having smoked at least 100 cigarettes 
during their lifetime and reported smoking every day or some 
days at the time of the survey (Centers for Disease Control and 
Prevention, 2012a). For use of other tobacco products, we cre-
ated a composite variable to capture whether participants had 
ever used: hookah or water pipe; traditional cigar, cigarillo or 
little cigar; dissolvable tobacco; or electronic cigarettes. The 
survey instrument is available online: www.unc.edu/~ntbrewer.
Data Analysis
We first calculated descriptive statistics, including the percent-
age of the sample that had ever heard of each constituent and 
the mean score for worry and discouragement from smoking 
for each constituent. We then used McNemar’s test to deter-
mine whether the proportion of people who believe that each 
constituent is added to cigarettes differed from the proportion 
of people who believe that the constituent naturally occurs in 
tobacco smoke. Next, we identified correlates of discourage-
ment from wanting to smoke for each constituent. Finally, we 
conducted bivariate linear regressions to examine predictors 
of discouragement from wanting to smoke across all constitu-
ents. We then entered variables with p values <.10 into a single 
multivariate model. Analyses used SPSS Statistics version 19.0 
with two-tailed tests and a critical α of .05.
results
About half of participants were female (54%) and most were 
aged 30 or older (61%). Our sample was mostly non-Hispanic 
(95%) and White (83%). Most participants had at least some 
college education (85%) and had an annual household income 
of at least $30,000 per year (69%). About of half of partici-
pants (51%) lived in a suburban area; the remainder of the sam-
ple lived either in a rural area (25%) or an urban area (24%). 
Almost a third of participants were current smokers (30%), 
25% were former smokers, and the remaining 44% were non-
smokers. About two thirds of the sample (66%) had ever used a 
tobacco product besides cigarettes.
Awareness
Most participants reported that they had heard of ammonia 
(99%), arsenic (97%), benzene (75%), cadmium (66%), carbon 
monoxide (100%), formaldehyde (94%), and nicotine (100%) 
(Table 1). Fewer than 30% were aware of four constituents, and 
awareness was in the single digits for the remaining nine con-
stituents. Participants tended to report higher levels of worry 
and discouragement from smoking when asked about constitu-
ents they recognized. For example, the highest levels of worry 
and discouragement from smoking were associated with con-
stituents that at least 90% of participants had heard of (ammo-
nia, arsenic, carbon monoxide, and formaldehyde).
Constituents Versus Additives
Chemicals that companies add to cigarette tobacco (i.e., 
additives) made participants more worried about the harms 
of smoking than chemicals that naturally occur in cigarette 
smoke (p < .001; Figure 1). Similarly, cigarette tobacco addi-
tives caused more discouragement from wanting to smoke 
than chemicals that naturally occur in cigarette smoke 
(p < .001).
When asked to spontaneously recall constituents found in 
cigarettes, participants commonly mentioned nicotine, and 
they occasionally mentioned ammonia, arsenic, benzene, and 
formaldehyde. Less than 2% of the sample mentioned any 
of the remaining 15 constituents (Table  1). Of the five con-
stituents that at least 2% of respondents spontaneously men-
tioned, it was more common for participants to erroneously 
believe that arsenic, benzene, and formaldehyde were added 
to cigarette tobacco than that they were naturally occurring in 
cigarette smoke (p < .05 for all three constituents). However, 
participants were more likely to report that nicotine was natu-
rally occurring than to report that it was added to cigarettes 
(p < .001).
When asked about the 20 constituents by name, few 
respondents believed that constituents naturally occurred in 
cigarette smoke (Table 1), and most believed they were added 
to cigarette tobacco. More respondents believed 18 of the con-
stituents were added to cigarette tobacco than believed they 
were naturally occurring in cigarette smoke (each p < .001; 
Table 1). The opposite was true for carbon monoxide and nico-

































Figure 1. Worry and discouragement from wanting to smoke 
elicited by tobacco additives and tobacco smoke constituents.
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were naturally occurring in cigarette smoke than that they were 
added to cigarette tobacco (p < .001).
Discouragement From Wanting to Smoke
The mean discouragement across all constituents was 3.70 
(SD = 0.98). This corresponds to being between “somewhat” 
(=3) and “quite a bit” (=4) discouraged from wanting to smoke. 
The constituents that elicited the highest mean discouragement 
were ammonia (4.34, SD = 1.00), arsenic (4.61, SD = 0.81), 
carbon monoxide (4.13, SD = 1.23), and formaldehyde (4.38, 
SD = 1.02; Table 1, elements in bold). Smokers and nonsmok-
ers rated these same four constituents as causing the most dis-
couragement from smoking (data not shown; please refer to 
Supplementary Table 1). Nicotine elicited the lowest mean dis-
couragement among smokers (2.42, SD = 1.38).
Bivariate analyses used discouragement elicited by each 
constituent as the outcome. For example, the first cell of 
Table  2 indicates that the correlation between belief that 
tobacco companies add butadiene to tobacco and discourage-
ment from wanting to smoke elicited by butadiene is .15. The 
strongest bivariate correlate of discouragement was worry 
(mean r = .89; Table 2). For all but two constituents, negative 
smoker prototype was a stronger correlate (mean r = .30) than 
positive smoker prototype (mean r = −.18). We grouped former 
smokers with nonsmokers because they reported similar lev-
els of constituents discouraging them from smoking (p = .98). 
Smokers had lower discouragement for all constituents than 
nonsmokers (mean r = −.36). Smoking status was not corre-
lated with awareness for any of the constituents, and smok-
ing was weakly correlated with belief that companies add 
constituents to tobacco for only 4 of the 20 constituents (data 
not shown; please refer to Supplementary Table 2).
The final multivariate analysis used average discouragement 
across the constituents as the outcome (Table 3). Mean discour-
agement from wanting to smoke was most strongly associated 
with being a nonsmoker (β  =  −.34). The mean discourage-
ment among smokers was 3.04 (SD  =  0.93), compared with 
3.98 (SD  =  0.86) among nonsmokers. Mean discouragement 
was also associated with greater belief that constituents are 
added to tobacco (β = .14), having negative smoker prototypes 
(β = .19), and older age (β = .16). To better understand the asso-
ciation with age, we examined mean discouragement by age 
categories: age 18–24, mean = 3.54 (SD = 0.84); age 25–39, 
mean = 3.61 (SD = 0.99); age 40–55, mean = 3.93 (SD = 0.94); 
and age 55 and older, mean = 3.95 (SD = 1.16). Belief that con-
stituents are added to tobacco was not statistically significant in 
bivariate regression (p = .09); this variable became statistically 
significant when we included smoking status in the model (p < 
.01). The multivariate model did not include worry as it was so 
highly correlated with discouragement.
DisCussiOn
Tobacco is likely the most important source of toxic chemical 
exposure and chemically caused disease (Rodgman & Perfetti, 
2008; Talhout et al., 2011). Yet few participants in our study 
had heard of many of the 20 constituents that the FDA has pri-
oritized for tobacco manufacturers to report to FDA and the 
public. Nearly all respondents (more than 95%) had heard of 
nicotine, carbon monoxide, ammonia, and arsenic, and most 











(%) (mean) (mean) (%) (%) p value (%) (%) p value
1,3-Butadiene 9 3.48 3.49 – – 75 13 <.001
1-Aminonaphthalene 7 3.46 3.50 – – 76 13 <.001
2-Aminonaphthalene 6 3.45 3.46 – – 74 15 <.001
4-Aminobiphenyl 6 3.49 3.47 – – 76 12 <.001
Acetaldehyde 23 3.66 3.60 – – 78 12 <.001
Acrolein 6 3.38 3.38 – – 73 15 <.001
Acrylonitrile 8 3.49 3.50 – – 76 13 <.001
Ammonia 99 4.39 4.34 12 8 .20 74 23 <.001
Arsenic 97 4.65 4.61 12 6 .01 72 25 <.001
Benzene 75 3.86 3.86 5 2 .03 74 21 <.001
Benzo[a]pyrene 25 3.57 3.58 – – 75 15 <.001
Cadmium 66 3.62 3.59 – – 62 30 <.001
Carbon monoxide 100 4.16 4.13 – – 23 73 <.001
Crotonaldehyde 4 3.52 3.54 – – 77 11 <.001
Formaldehyde 94 4.45 4.38 16 3 <.001 82 12 <.001
Isoprene 21 3.37 3.40 – – 69 19 <.001
Nicotine 100 3.44 3.46 35 52 <.001 32 76 <.001
NNK 6 3.57 3.58 – – 66 24 <.001
NNN 4 3.49 3.50 – – 66 27 <.001
Toluene 29 3.55 3.57 – – 72 17 <.001
Note. NNK = nicotine-derived nitrosamine ketone; NNN = N-nitrosonornicotine. Elements in bold indicate constituents that elicit 
the highest discouragement; (–) indicates that <2% of respondents spontaneously mentioned the constituent. N = 300.
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had heard of benzene, cadmium, and formaldehyde. Studies 
of smokers and nonsmokers in the United States, Canada, 
Australia, and the United Kingdom (Borland & Hill, 1997; 
Environics Research Group, 2008; Hammond, Fong, McNeill, 
Borland, & Cummings, 2006; Siahpush, McNeill, Hammond, 
& Fong, 2006; Stockwell, Rutley, & Clark, 1992) have also 
found that the public has very high awareness of nicotine and 
carbon monoxide (Hammond et al., 2006; Siahpush et al., 2006; 
Stockwell et al., 1992), but they are less familiar with arsenic, 
ammonia, benzene, and formaldehyde (Environics Research 
Group, 2008). These studies did not ask participants about the 
other 13 constituents on the FDA’s high priority list, like acetal-
dehyde, acrolein, or NNK, which few participants in our study 
had heard of. These previous studies also did not examine how 
information about tobacco constituents might convey health 
risks or discourage people from smoking, another novel aspect 
of our research findings.
One important question is how people perceive constitu-
ents they have never heard of compared to constituents with 
which they are familiar. Our study found that chemicals that 
most people had heard of tended to cause stronger feelings of 
worry and discouragement. This finding stands in contrast to 
research on health warnings that has shown that introducing 
some novel concepts can be more effective than reinforcing 
existing knowledge (Borland, 1997; Hammond et al., 2007). 
This is in part because the impact of tobacco warnings tends 
to diminish over time (Hammond, 2009). However, to our 
knowledge, the impact of messages about familiar compared 
to unfamiliar constituents has not been studied, and merits 
further research. If future studies corroborate our findings, 
health communication campaigns to discourage smoking 
could consider emphasizing widely recognized constituents 
(e.g., ammonia, carbon monoxide) in their materials and mes-
sages, instead of chemicals that most people have not heard of 
(e.g., NNK, acrolein), at least until the public becomes more 
aware of them. An alternative is to conduct communication 
campaigns to raise public awareness of some of these dan-
gerous chemicals to develop their suitability for discouraging 
smoking.
Few people in our study correctly understood that constitu-
ents are naturally present in tobacco, and many instead believed 
they are added by tobacco companies. Furthermore, substances 
people perceived as added to cigarettes by tobacco companies 
elicited more discouragement from wanting to smoke than 
substances they perceived as naturally occurring in tobacco. 
Additives also made participants more worried about the harms 
of smoking than chemicals that naturally occur in cigarette 
smoke. The tobacco industry has consistently marketed certain 
brands of cigarettes as “natural” and “additive-free,” which 
can create the false perception that additive-free cigarettes are 
safer than regular cigarettes (Wilkenfeld, Henningfield, Slade, 
Burns, & Pinney, 2000). A national survey of U.S. adult smok-
ers found that 73% incorrectly believed that cigarettes with 
additives are more harmful than cigarettes that do not have 
additives (Cummings et  al., 2004). Communications cam-
paigns that focus on constituents may face multiple challenges, 
as people may misunderstand tobacco constituents to be less 
harmful than additives and find constituents less motivat-
ing than additives. Thus, health communication efforts might 
be more effective if they emphasize that all cigarettes—even 
table 2. Correlates of Discouragement From Wanting to Smoke, by Tobacco Constituent
Belief that tobacco 
companies add 
constituents to 
tobacco (r) Awareness (r)
Prototype of smoker 
as good (r)
Prototype of smoker 
as bad (r) Smoking status (r) Worry (r)
1,3-Butadiene .15* .23* −.19* .31* −.38* .90*
1-Aminonaphthalene .12* .14* −.17* .28* −.39* .90*
2-Aminonaphthalene .05 .18* −.13* .34* −.33* .88*
4-Aminobiphenyl .13* .13* −.14* .28* −.30* .92*
Acetaldehyde .09 .22* −.22* .33* −.35* .87*
Acrolein .14* .22* −.12* .25* −.28* .89*
Acrylonitrile .05 .20* −.16* .33* −.36* .87*
Ammonia .04 .04 −.22* .30* −.34* .88*
Arsenic −.05 .28* −.20* .26* −.34* .83*
Benzene .09 .23* −.24* .37* −.41* .89*
Benzo[a]pyrene .11 .29* −.13* .28* −.29* .89*
Cadmium .15* .13* −.16* .25* −.36* .93*
Carbon monoxide .20* .05 −.27* .25* −.40* .88*
Crotonaldehyde .03 .07 −.17* .30* −.38* .88*
Formaldehyde .03 .22* −.28* .26* −.33* .85*
Isoprene .11 .21* −.14* .26* −.36* .90*
Nicotine .18* .02 −.17* .32* −.47* .90*
NNK .16* .06 −.13* .30* −.34* .91*
NNN .20* .15* −.09 .30* −.39* .90*
Toluene .11 .29* −.17* .31* −.36* .89*
Mean r .10 .17 −.18 .30 −.36 .89
Note. NNK = nicotine-derived nitrosamine ketone; NNN = N-nitrosonornicotine. Elements in bold indicate constituents that elicit 
the highest discouragement. Correlation coefficients (rs) characterize the bivariate relationship between the variables in each 




so-called “natural” and “additive-free” cigarettes—are irrevo-
cably dangerous because they contain harmful components.
In adjusted analyses, nonsmokers were more likely than 
smokers to report that constituents discouraged them from 
smoking. This finding is consistent with research indicat-
ing differences in attitudes and beliefs according to smoking 
status (Poland et  al., 2000). Smokers are more resistant than 
nonsmokers to information on the health risks of smoking 
and, as a result, more extensively underestimate their health 
risks (Cameron, Pepper, & Brewer, in press; Harris, Cohen, 
Wyrwich, & Luke, 2011; Strecher, Kreuter, & Kobrin, 1995). 
One reason is that some smokers may spend less time look-
ing at risk information than nonsmokers (Loeber et al., 2011). 
Consequently, efforts to communicate information about con-
stituents should design messages carefully with the understand-
ing that smokers are likely to be less attentive to the warnings. 
These findings support the use of vivid cigarette pack warnings 
to increase the chance of drawing the attention of smokers to 
the key messages.
In our study, respondents with more negative images of 
smokers (i.e., prototypes) were more likely to report that con-
stituents discouraged them from smoking. Research has found 
that individuals’ perceptions of a “typical smoker” are strong 
predictors of attitudes and behavior (Gibbons & Eggleston, 
1996; Gibbons & Gerrard, 1995; Pepper et  al., 2013). One 
cessation study found that smokers were more likely to relapse 
if they had positive perceptions of the typical smoker (Gibbons 
& Eggleston, 1996). Another recent study found that adoles-
cent nonsmokers with negative images of smokers were signifi-
cantly less willing to try e-cigarettes than those with positive 
images of smokers (Pepper et al., 2013). Thus, images of smok-
ers may be an important predictor of smoking-related attitudes 
and behavior. In the context of this study, our data suggest that 
adults with negative images of smokers might be more recep-
tive to constituent-related health information than those who 
have positive images of smokers.
Study strengths include gathering highly novel data on 
beliefs about tobacco constituents and our national sample 
that included both smokers and nonsmokers. Study limita-
tions include the cross-sectional study design, which limits 
our ability to infer causal relations among variables. The non-
probability sampling approach and low inclusion of minority 
respondents may limit the generalizability of our findings. As 
communication about and discussion of tobacco constituents 
grows, the patterns of relationships we found among variables 
may also evolve.
This early look at how Americans think about constituents 
should be replicated with a larger and more diverse popula-
tion to better understand how subgroups that experience 
smoking-related health disparities (e.g., by race, income, 
table 3. Correlates of Discouragement From Wanting to Smoke, Across Tobacco Constituents
Discouragement Bivariate Multivariate
Mean (SD) β β
Belief that constituents are added to tobacco .10 .14*
Awareness .17* .10
Prototype of smoker as good −.21* −.09
Prototype of smoker as bad .36* .19*
Smoking status −.44* −.34*
 Current smoker 3.04 (0.93)
 Nonsmoker 3.98 (0.86)
Ever used other tobacco products −.18* .03
 Yes 3.57 (0.98)
 No 3.94 (0.95)
Age .15* .16*
Sex .12* .04
 Male 3.57 (0.95)
 Female 3.82 (1.00)
Sexual orientation .02
 Heterosexual 3.69 (0.99)
 Nonheterosexual 3.78 (0.83)
Ethnicity .00
 Hispanic 3.68 (0.74)
 Non-Hispanic 3.70 (1.00)
Race .10 .08
 White 3.65 (0.98)
 Non-White 3.92 (0.97)
Education .13* −.00
Household income, annual .15* .04
Urbanicity .03
 Rural 3.65 (1.06)
 Urban or suburban 3.72 (0.96)
Health literacy −.11 −.09
Note. Multivariate analysis provided standardized regression coefficients (βs). The regression model included variables with  
p values <.10 in bivariate analyses. Analyses treated age, education, and income as continuous variables.
*p < .05.
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sexual orientation) respond to information about constituents. 
Youth and adolescents are of particular interest as this group 
is at highest risk of smoking initiation (Centers for Disease 
Control and Prevention, 2012b; The Substance Abuse and 
Mental Health Services Administration, 2011). Future stud-
ies should examine the effectiveness of different methods of 
conveying constituent information to consumers (e.g., numeri-
cal vs. descriptive information) (Gallopel-Morvan et al., 2011; 
Hammond, 2009), as well as the extent to which FDA’s con-
stituent-related dissemination efforts are understandable to the 
public. Previously, consumers have misconstrued information 
about tar and nicotine levels, perceiving certain products as 
less harmful than others (Cohen, 1996; Pollay & Dewhirst, 
2001). Likewise, as constituent levels differ by cigarette prod-
uct and brand (Wu, Zhang, Jain, Ashley, & Watson, 2005), 
FDA must anticipate possible unintended consequences of 
releasing new constituent information. Therefore, future stud-
ies should investigate the potential unintended consequences 
of publicizing information about constituents. Our results 
can inform efforts by FDA and others organizations as they 
develop health communications campaigns, for example as 
FDA develops new cigarette pack warnings. Future research 
should develop and evaluate warning messages that convey 
information about tobacco constituents.
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